Publications
403 found
Show per page
Wälchli-Popovic, Milica, Monnerat, Sophie, Taylor, Angela E., Gilligan, Lorna C., Schiffer, Lina, Arlt, Wiebke, Vogt, Deborah R., De Geyter, Christian, Hutter, Nina, Donath, Marc Y., Sartorius, Gideon, & Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1435698
. (2024). Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome—the FertIL trial [Journal-article].
Wälchli-Popovic, Milica, Monnerat, Sophie, Taylor, Angela E., Gilligan, Lorna C., Schiffer, Lina, Arlt, Wiebke, Vogt, Deborah R., De Geyter, Christian, Hutter, Nina, Donath, Marc Y., Sartorius, Gideon, & Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1435698
. (2024). Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome—the FertIL trial [Journal-article].
Fleseriu, M., Christ-Crain, M., Langlois, F., Gadelha, M., & Melmed, S. (2024). Hypopituitarism. The Lancet, 403(10444), 2632–2648. https://doi.org/10.1016/s0140-6736(24)00342-8
Fleseriu, M., Christ-Crain, M., Langlois, F., Gadelha, M., & Melmed, S. (2024). Hypopituitarism. The Lancet, 403(10444), 2632–2648. https://doi.org/10.1016/s0140-6736(24)00342-8
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial [Journal-article]. eClinicalMedicine, 68, 102429. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial [Journal-article]. eClinicalMedicine, 68, 102429. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial [Journal-article]. eClinicalMedicine, 68, 102429. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial [Journal-article]. eClinicalMedicine, 68, 102429. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial [Journal-article]. eClinicalMedicine, 68, 102429. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial [Journal-article]. eClinicalMedicine, 68, 102429. https://doi.org/10.1016/j.eclinm.2024.102429
Atila, Cihan, Beck, Julia, Refardt, Julie, Erlic, Zoran, Drummond, Juliana B., Sailer, Clara O., Liechti, Matthias E., Rocha, Beatriz Santana Soares, Beuschlein, Felix, Winzeler, Bettina, & European Journal of Endocrinology, 190, 354–362. https://doi.org/10.1093/ejendo/lvae040
. (2024). Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls.
Atila, Cihan, Beck, Julia, Refardt, Julie, Erlic, Zoran, Drummond, Juliana B., Sailer, Clara O., Liechti, Matthias E., Rocha, Beatriz Santana Soares, Beuschlein, Felix, Winzeler, Bettina, & European Journal of Endocrinology, 190, 354–362. https://doi.org/10.1093/ejendo/lvae040
. (2024). Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls.
Atila, Cihan, Refardt, Julie, & Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-024-00998-6
. (2024). Correction to: Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency (Nature Reviews Endocrinology, (2024), 10.1038/s41574-024-00985-x).
Atila, Cihan, Refardt, Julie, & Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-024-00998-6
. (2024). Correction to: Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency (Nature Reviews Endocrinology, (2024), 10.1038/s41574-024-00985-x).
Atila, Cihan, Refardt, Julie, & Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-024-00985-x
. (2024). Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency.
Atila, Cihan, Refardt, Julie, & Nature Reviews Endocrinology. https://doi.org/10.1038/s41574-024-00985-x
. (2024). Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency.
Efthymiadis, Agathoklis, Pofi, Riccardo, Rostom, Hussam, James, Tim, Shine, Brian, Guha, Nish, Cudlip, Simon, Endocrinology, Diabetes and Metabolism, 7. https://doi.org/10.1002/edm2.467
, & Pal, Aparna. (2024). Copeptin and the syndrome of inappropriate antidiuresis (SIAD) after pituitary transsphenoidal surgery.
Efthymiadis, Agathoklis, Pofi, Riccardo, Rostom, Hussam, James, Tim, Shine, Brian, Guha, Nish, Cudlip, Simon, Endocrinology, Diabetes and Metabolism, 7. https://doi.org/10.1002/edm2.467
, & Pal, Aparna. (2024). Copeptin and the syndrome of inappropriate antidiuresis (SIAD) after pituitary transsphenoidal surgery.
Huynh, Tony, Signal, Dana, & Clinical Endocrinology, null. https://doi.org/10.1111/cen.15011
. (2024). Paediatric perspectives in the diagnosis of polyuria-polydipsia syndrome.
Huynh, Tony, Signal, Dana, & Clinical Endocrinology, null. https://doi.org/10.1111/cen.15011
. (2024). Paediatric perspectives in the diagnosis of polyuria-polydipsia syndrome.
Kriemler, Lilian, Rudin, Salome, Gawinecka, Joanna, Gross, Felix, Arnold, Markus, Schweizer, Juliane, Westphal, Laura, Inauen, Corinne, Pokorny, Thomas, Dittrich, Tolga, Toebak, Anna, Arnold, Marcel, European Stroke Journal, 9, 494–500. https://doi.org/10.1177/23969873231221619
, von Eckardstein, Arnold, Rentsch, Katharina, Katan, Mira, & De Marchis, Gian Marco. (2024). Discordance between LDL-C and apolipoprotein B is associated with large-artery-atherosclerosis ischemic stroke in patients ⩽70 years of age.
Kriemler, Lilian, Rudin, Salome, Gawinecka, Joanna, Gross, Felix, Arnold, Markus, Schweizer, Juliane, Westphal, Laura, Inauen, Corinne, Pokorny, Thomas, Dittrich, Tolga, Toebak, Anna, Arnold, Marcel, European Stroke Journal, 9, 494–500. https://doi.org/10.1177/23969873231221619
, von Eckardstein, Arnold, Rentsch, Katharina, Katan, Mira, & De Marchis, Gian Marco. (2024). Discordance between LDL-C and apolipoprotein B is associated with large-artery-atherosclerosis ischemic stroke in patients ⩽70 years of age.
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial. eClinicalMedicine, 68. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial. eClinicalMedicine, 68. https://doi.org/10.1016/j.eclinm.2024.102429
Radvanyi, Z., Yoo, E. J., Kandasamy, P., Salas-Bastos, A., Monnerat, S., Refardt, J., Christ-Crain, M., Hayashi, H., Kondo, Y., Jantsch, J., Rubio-Aliaga, I., Sommer, L., Wagner, C. A., Hediger, M. A., Kwon, H. M., Loffing, J., & Pathare, G. (2024). Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation [Journal-article]. Journal of Biological Chemistry, 300, 105480. https://doi.org/10.1016/j.jbc.2023.105480
Radvanyi, Z., Yoo, E. J., Kandasamy, P., Salas-Bastos, A., Monnerat, S., Refardt, J., Christ-Crain, M., Hayashi, H., Kondo, Y., Jantsch, J., Rubio-Aliaga, I., Sommer, L., Wagner, C. A., Hediger, M. A., Kwon, H. M., Loffing, J., & Pathare, G. (2024). Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation [Journal-article]. Journal of Biological Chemistry, 300, 105480. https://doi.org/10.1016/j.jbc.2023.105480
Refardt, Julie, Vogt, Deborah R., & New England Journal of Medicine, 390, 288–290. https://doi.org/10.1056/nejmc2314326
. (2024). Arginine or Hypertonic Saline-Stimulated Copeptin to Diagnose AVP Deficiency.
Refardt, Julie, Vogt, Deborah R., & New England Journal of Medicine, 390, 288–290. https://doi.org/10.1056/nejmc2314326
. (2024). Arginine or Hypertonic Saline-Stimulated Copeptin to Diagnose AVP Deficiency.
Rudin, Salome, Kriemler, Lilian, Dittrich, Tolga D., Zietz, Annaelle, Schweizer, Juliane, Arnold, Markus, Peters, Nils, Barinka, Filip, Jung, Simon, Arnold, Marcel, Fischer, Urs, Rentsch, Katharina, Swiss Medical Weekly, 154. https://doi.org/10.57187/s.3633
, Katan, Mira, & De Marchis, Gian Marco. (2024). Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center.
Rudin, Salome, Kriemler, Lilian, Dittrich, Tolga D., Zietz, Annaelle, Schweizer, Juliane, Arnold, Markus, Peters, Nils, Barinka, Filip, Jung, Simon, Arnold, Marcel, Fischer, Urs, Rentsch, Katharina, Swiss Medical Weekly, 154. https://doi.org/10.57187/s.3633
, Katan, Mira, & De Marchis, Gian Marco. (2024). Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center.
Refardt, J., Atila, C., Chifu, I., Ferrante, E., Erlic, Z., Drummond, J. B., Indirli, R., Drexhage, R. C., Sailer, C. O., Widmer, A., Felder, S., Powlson, A. S., Hutter, N., Vogt, D. R., Gurnell, M., Soares, B. S., Hofland, J., Beuschlein, F., Fassnacht, M., et al. (2023). Arginine or Hypertonic Saline–Stimulated Copeptin to Diagnose AVP Deficiency [Journal-article]. New England Journal of Medicine, 389(20), 1877–1887. https://doi.org/10.1056/nejmoa2306263
Refardt, J., Atila, C., Chifu, I., Ferrante, E., Erlic, Z., Drummond, J. B., Indirli, R., Drexhage, R. C., Sailer, C. O., Widmer, A., Felder, S., Powlson, A. S., Hutter, N., Vogt, D. R., Gurnell, M., Soares, B. S., Hofland, J., Beuschlein, F., Fassnacht, M., et al. (2023). Arginine or Hypertonic Saline–Stimulated Copeptin to Diagnose AVP Deficiency [Journal-article]. New England Journal of Medicine, 389(20), 1877–1887. https://doi.org/10.1056/nejmoa2306263
Monnerat S, One Liter a Day, Keeps the Doctor Away. (Patent No. 11). 108(11), Article 11. https://doi.org/10.1210/clinem/dgad217
, & Refardt J. (2023).
Monnerat S, One Liter a Day, Keeps the Doctor Away. (Patent No. 11). 108(11), Article 11. https://doi.org/10.1210/clinem/dgad217
, & Refardt J. (2023).
Smit, J. M., Van Der Zee, P. A., Stoof, S. C. M., Van Genderen, M. E., Snijders, D., Boersma, W. G., Confalonieri, P., Salton, F., Confalonieri, M., Shih, M.-C., Meduri, G. U., Dequin, P.-F., Le Gouge, A., Lloyd, M., Karunajeewa, H., Bartminski, G., Fernández-Serrano, S., Suárez-Cuartín, G., van Klaveren, D., et al. (2023). Predicting individualized treatment effects of corticosteroids in community-acquired-pneumonia: a data-driven analysis of randomized controlled trials [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.10.03.23296132
Smit, J. M., Van Der Zee, P. A., Stoof, S. C. M., Van Genderen, M. E., Snijders, D., Boersma, W. G., Confalonieri, P., Salton, F., Confalonieri, M., Shih, M.-C., Meduri, G. U., Dequin, P.-F., Le Gouge, A., Lloyd, M., Karunajeewa, H., Bartminski, G., Fernández-Serrano, S., Suárez-Cuartín, G., van Klaveren, D., et al. (2023). Predicting individualized treatment effects of corticosteroids in community-acquired-pneumonia: a data-driven analysis of randomized controlled trials [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.10.03.23296132
Monnerat S, Refardt J, Potasso L, Meier C, & The Journal of Clinical Endocrinology and Metabolism, 108(10), e1027–e1033. https://doi.org/10.1210/clinem/dgad238
. (2023). An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD.
Monnerat S, Refardt J, Potasso L, Meier C, & The Journal of Clinical Endocrinology and Metabolism, 108(10), e1027–e1033. https://doi.org/10.1210/clinem/dgad238
. (2023). An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD.
Warren AM, Grossmann M, Endocrine Reviews, 44(5), 819–861. https://doi.org/10.1210/endrev/bnad010
, & Russell N. (2023). Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management.
Warren AM, Grossmann M, Endocrine Reviews, 44(5), 819–861. https://doi.org/10.1210/endrev/bnad010
, & Russell N. (2023). Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management.
Sterns RH, Rondon-Berrios H, Adrogué HJ, Berl T, Burst V, Cohen DM, Clinical Journal of the American Society of Nephrology : CJASN. https://doi.org/10.2215/cjn.0000000000000244
, Cuesta M, Decaux G, Emmett M, Garrahy A, Gankam-Kengne F, Hix JK, Hoorn EJ, Kamel KS, Madias NE, Peri A, Refardt J, Rosner MH, et al. (2023). Treatment Guidelines for Hyponatremia: Stay the Course.
Sterns RH, Rondon-Berrios H, Adrogué HJ, Berl T, Burst V, Cohen DM, Clinical Journal of the American Society of Nephrology : CJASN. https://doi.org/10.2215/cjn.0000000000000244
, Cuesta M, Decaux G, Emmett M, Garrahy A, Gankam-Kengne F, Hix JK, Hoorn EJ, Kamel KS, Madias NE, Peri A, Refardt J, Rosner MH, et al. (2023). Treatment Guidelines for Hyponatremia: Stay the Course.
Radvanyi, Z., Yoo, E. J., Kandasamy, P., Salas-Bastos, A., Monnerat, S., Refardt, J., Christ-Crain, M., Hayashi, H., Kondo, Y., Jantsch, J., Rubio-Aliaga, I., Sommer, L., Wagner, C. A., Hediger, M. A., Kwon, H. M., Loffing, J., & Pathare, G. (2023). Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.06.23.546282
Radvanyi, Z., Yoo, E. J., Kandasamy, P., Salas-Bastos, A., Monnerat, S., Refardt, J., Christ-Crain, M., Hayashi, H., Kondo, Y., Jantsch, J., Rubio-Aliaga, I., Sommer, L., Wagner, C. A., Hediger, M. A., Kwon, H. M., Loffing, J., & Pathare, G. (2023). Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.06.23.546282
Pelouto A, Refardt JC, European Journal of Endocrinology, 188(3), 322–330. https://doi.org/10.1093/ejendo/lvad028
, Zandbergen AAM, & Hoorn EJ. (2023). Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia.
Pelouto A, Refardt JC, European Journal of Endocrinology, 188(3), 322–330. https://doi.org/10.1093/ejendo/lvad028
, Zandbergen AAM, & Hoorn EJ. (2023). Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia.
Sailer CO, Gaisl O, Beglinger S, Frech-Dörfler M, Sommer V, Lüthy MH, & European Journal of Endocrinology, 188(3). https://doi.org/10.1093/ejendo/lvad022
. (2023). Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis.
Sailer CO, Gaisl O, Beglinger S, Frech-Dörfler M, Sommer V, Lüthy MH, & European Journal of Endocrinology, 188(3). https://doi.org/10.1093/ejendo/lvad022
. (2023). Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis.
Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., eClinicalMedicine, 57, 101865. https://doi.org/10.1016/j.eclinm.2023.101865
, & Winzeler, Bettina. (2023). Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial [Journal-article].
Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., eClinicalMedicine, 57, 101865. https://doi.org/10.1016/j.eclinm.2023.101865
, & Winzeler, Bettina. (2023). Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial [Journal-article].
Workeneh BT, Meena P, Advances in Kidney Disease and Health, 30(2), 85–101. https://doi.org/10.1053/j.akdh.2022.11.004
, & Rondon-Berrios H. (2023). Hyponatremia Demystified: Integrating Physiology to Shape Clinical Practice.
Workeneh BT, Meena P, Advances in Kidney Disease and Health, 30(2), 85–101. https://doi.org/10.1053/j.akdh.2022.11.004
, & Rondon-Berrios H. (2023). Hyponatremia Demystified: Integrating Physiology to Shape Clinical Practice.
Monnerat S, Atila C, Refardt J, & Journal of the Endocrine Society, 7(4), bvad011. https://doi.org/10.1210/jendso/bvad011
. (2023). Prevalence of Admission Hyponatremia in Patients With Diabetes Treated With and Without an SGLT2 inhibitor.
Monnerat S, Atila C, Refardt J, & Journal of the Endocrine Society, 7(4), bvad011. https://doi.org/10.1210/jendso/bvad011
. (2023). Prevalence of Admission Hyponatremia in Patients With Diabetes Treated With and Without an SGLT2 inhibitor.
Refardt J, Imber C, Nobbenhuis R, Sailer CO, Haslbauer A, Monnerat S, Bathelt C, Vogt DR, Berres M, Winzeler B, Bridenbaugh SA, & Journal of the American Society of Nephrology : JASN, 34(2), 322–332. https://doi.org/10.1681/asn.2022050623
. (2023). Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Refardt J, Imber C, Nobbenhuis R, Sailer CO, Haslbauer A, Monnerat S, Bathelt C, Vogt DR, Berres M, Winzeler B, Bridenbaugh SA, & Journal of the American Society of Nephrology : JASN, 34(2), 322–332. https://doi.org/10.1681/asn.2022050623
. (2023). Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Arima H, Cheetham T, Hormone Research in Paediatrics, 96(4), 423–425. https://doi.org/10.1159/000527139
, Cooper DL, Drummond JB, Gurnell M, Levy M, McCormack A, Newell-Price JD, Verbalis JG, & Wass J. (2023). Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus.
Arima H, Cheetham T, Hormone Research in Paediatrics, 96(4), 423–425. https://doi.org/10.1159/000527139
, Cooper DL, Drummond JB, Gurnell M, Levy M, McCormack A, Newell-Price JD, Verbalis JG, & Wass J. (2023). Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus.
Atila, Cihan, Holze, Friederike, Murugesu, Rakithan, Rommers, Nikki, Hutter, Nina, Varghese, Nimmy, Sailer, Clara O, Eckert, Anne, Heinrichs, Markus, Liechti, Matthias E, & The Lancet Diabetes and Endocrinology, 11, 454–464. https://doi.org/10.1016/s2213-8587(23)00120-1
. (2023). Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Atila, Cihan, Holze, Friederike, Murugesu, Rakithan, Rommers, Nikki, Hutter, Nina, Varghese, Nimmy, Sailer, Clara O, Eckert, Anne, Heinrichs, Markus, Liechti, Matthias E, & The Lancet Diabetes and Endocrinology, 11, 454–464. https://doi.org/10.1016/s2213-8587(23)00120-1
. (2023). Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Baur, Fabienne, Atila, Cihan, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Bathelt, Cemile, BMJ Nutrition, Prevention and Health, 6, 301–309. https://doi.org/10.1136/bmjnph-2023-000781
, & Winzeler, Bettina. (2023). Gender differences in weight gain during attempted and successful smoking cessation on dulaglutide treatment: A predefined secondary analysis of a randomised trial.
Baur, Fabienne, Atila, Cihan, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Bathelt, Cemile, BMJ Nutrition, Prevention and Health, 6, 301–309. https://doi.org/10.1136/bmjnph-2023-000781
, & Winzeler, Bettina. (2023). Gender differences in weight gain during attempted and successful smoking cessation on dulaglutide treatment: A predefined secondary analysis of a randomised trial.
Blum, Claudine A., Roethlisberger, Eva A., Cesana-Nigro, Nicole, Winzeler, Bettina, Rodondi, Nicolas, Blum, Manuel R., Briel, Matthias, Mueller, Beat, BMC Pulmonary Medicine, 23. https://doi.org/10.1186/s12890-023-02794-w
, & Schuetz, Philipp. (2023). Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial.
Blum, Claudine A., Roethlisberger, Eva A., Cesana-Nigro, Nicole, Winzeler, Bettina, Rodondi, Nicolas, Blum, Manuel R., Briel, Matthias, Mueller, Beat, BMC Pulmonary Medicine, 23. https://doi.org/10.1186/s12890-023-02794-w
, & Schuetz, Philipp. (2023). Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial.
Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Coynel, David, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Zanchi, Davide, Erlanger, Tobias E., Trials, 24. https://doi.org/10.1186/s13063-023-07164-9
, & Winzeler, Bettina. (2023). Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)—a structured summary of a study protocol for a randomized controlled study.
Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Coynel, David, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Zanchi, Davide, Erlanger, Tobias E., Trials, 24. https://doi.org/10.1186/s13063-023-07164-9
, & Winzeler, Bettina. (2023). Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)—a structured summary of a study protocol for a randomized controlled study.
Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., eClinicalMedicine, 57. https://doi.org/10.1016/j.eclinm.2023.101865
, & Winzeler, Bettina. (2023). Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial.
Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., eClinicalMedicine, 57. https://doi.org/10.1016/j.eclinm.2023.101865
, & Winzeler, Bettina. (2023). Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial.
Monnerat, Sophie, Atila, Cihan, Baur, Fabienne, de Jesus, Joyce Santos, Refardt, Julie, Dickenmann, Michael, & European Journal of Endocrinology, 189, 252–261. https://doi.org/10.1093/ejendo/lvad108
. (2023). Effect of protein supplementation on plasma sodium levels in the syndrome of inappropriate antidiuresis: a monocentric, open-label, proof-of-concept study—the TREASURE study.
Monnerat, Sophie, Atila, Cihan, Baur, Fabienne, de Jesus, Joyce Santos, Refardt, Julie, Dickenmann, Michael, & European Journal of Endocrinology, 189, 252–261. https://doi.org/10.1093/ejendo/lvad108
. (2023). Effect of protein supplementation on plasma sodium levels in the syndrome of inappropriate antidiuresis: a monocentric, open-label, proof-of-concept study—the TREASURE study.
Potasso, Laura, Monnerat, Sophie, Refardt, Julie, Lindner, Gregor, Burst, Volker, Winzeler, Bettina, & Journal of Clinical Endocrinology and Metabolism, 108, 2248–2254. https://doi.org/10.1210/clinem/dgad133
. (2023). Chloride and Potassium Assessment Is a Helpful Tool for Differential Diagnosis of Thiazide-Associated Hyponatremia.
Potasso, Laura, Monnerat, Sophie, Refardt, Julie, Lindner, Gregor, Burst, Volker, Winzeler, Bettina, & Journal of Clinical Endocrinology and Metabolism, 108, 2248–2254. https://doi.org/10.1210/clinem/dgad133
. (2023). Chloride and Potassium Assessment Is a Helpful Tool for Differential Diagnosis of Thiazide-Associated Hyponatremia.
Probst, L., Monnerat, S., Vogt, D. R., Lengsfeld, S., Burkard, T., Meienberg, A., Bathelt, C., Christ-Crain, M., & Winzeler, B. (2023). Effects of dulaglutide on alcohol consumption during smoking cessation. JCI Insight, 8. https://doi.org/10.1172/jci.insight.170419
Probst, L., Monnerat, S., Vogt, D. R., Lengsfeld, S., Burkard, T., Meienberg, A., Bathelt, C., Christ-Crain, M., & Winzeler, B. (2023). Effects of dulaglutide on alcohol consumption during smoking cessation. JCI Insight, 8. https://doi.org/10.1172/jci.insight.170419
Refardt, Julie, Atila, Cihan, & Reviews in Endocrine and Metabolic Disorders, null. https://doi.org/10.1007/s11154-023-09862-w
. (2023). New insights on diagnosis and treatment of AVP deficiency.
Refardt, Julie, Atila, Cihan, & Reviews in Endocrine and Metabolic Disorders, null. https://doi.org/10.1007/s11154-023-09862-w
. (2023). New insights on diagnosis and treatment of AVP deficiency.
Roth, Sofia, Flint, Emilio, Ghataore, Lea, Patel, Vishal C., Singanayagam, Arjuna, Vincent, Royce P., Triantafyllou, Evangelos, Ma, Yun, Bernal, William, Auzinger, Georg, Heneghan, Michael, Antoniades, Charalambos, Gastro Hep Advances, 2, 72–82. https://doi.org/10.1016/j.gastha.2022.08.006
, McPhail, Mark J.W., Taylor, David R., Wendon, Julia, & Bernsmeier, Christine. (2023). Low Baseline but Not Delta Cortisol Relates to 28-Day Transplant-Free Survival in Acute and Acute-on-Chronic Liver Failure.
Roth, Sofia, Flint, Emilio, Ghataore, Lea, Patel, Vishal C., Singanayagam, Arjuna, Vincent, Royce P., Triantafyllou, Evangelos, Ma, Yun, Bernal, William, Auzinger, Georg, Heneghan, Michael, Antoniades, Charalambos, Gastro Hep Advances, 2, 72–82. https://doi.org/10.1016/j.gastha.2022.08.006
, McPhail, Mark J.W., Taylor, David R., Wendon, Julia, & Bernsmeier, Christine. (2023). Low Baseline but Not Delta Cortisol Relates to 28-Day Transplant-Free Survival in Acute and Acute-on-Chronic Liver Failure.
Arima H, Cheetham T, The Journal of Clinical Endocrinology and Metabolism, 108(1), 1–3. https://doi.org/10.1210/clinem/dgac547
, Cooper D, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG, Wass J, & Working Group for Renaming Diabetes Insipidus. (2022). Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus.
Arima H, Cheetham T, The Journal of Clinical Endocrinology and Metabolism, 108(1), 1–3. https://doi.org/10.1210/clinem/dgac547
, Cooper D, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG, Wass J, & Working Group for Renaming Diabetes Insipidus. (2022). Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus.
Arima H, Bichet DG, Cheetham T, Changing the name of diabetes insipidus. (Patent No. 6). 25(6), Article 6. https://doi.org/10.1007/s11102-022-01276-2
, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG, Wass J, & Cooper D. (2022).
Arima H, Bichet DG, Cheetham T, Changing the name of diabetes insipidus. (Patent No. 6). 25(6), Article 6. https://doi.org/10.1007/s11102-022-01276-2
, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG, Wass J, & Cooper D. (2022).
Nahum U, Refardt J, Chifu I, Fenske WK, Fassnacht M, Szinnai G, European Journal of Endocrinology, 187(6), 777–786. https://doi.org/10.1530/eje-22-0368
, & Pfister M. (2022). Machine learning-based algorithm as an innovative approach for the differentiation between diabetes insipidus and primary polydipsia in clinical practice.
Nahum U, Refardt J, Chifu I, Fenske WK, Fassnacht M, Szinnai G, European Journal of Endocrinology, 187(6), 777–786. https://doi.org/10.1530/eje-22-0368
, & Pfister M. (2022). Machine learning-based algorithm as an innovative approach for the differentiation between diabetes insipidus and primary polydipsia in clinical practice.
Working Group for Renaming Diabetes Insipidus, Arima H, Cheetham T, Endocrine Journal, 69(11), 1281–1284. https://doi.org/10.1507/endocrj.ej20220831
, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J, & Wass JAH. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Working Group for Renaming Diabetes Insipidus, Arima H, Cheetham T, Endocrine Journal, 69(11), 1281–1284. https://doi.org/10.1507/endocrj.ej20220831
, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J, & Wass JAH. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Arima H, Cheetham T, Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus. 66, 868–870. https://doi.org/10.20945/2359-3997000000528
, Cooper DL, Drummond JB, Gurnell M, Levy M, McCormack A, Newell-Price JD, Verbalis JG, & Wass J. (2022).
Arima H, Cheetham T, Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus. 66, 868–870. https://doi.org/10.20945/2359-3997000000528
, Cooper DL, Drummond JB, Gurnell M, Levy M, McCormack A, Newell-Price JD, Verbalis JG, & Wass J. (2022).
Working Group for Renaming Diabetes Insipidus, Arima H, Cheetham T, Endocrine Connections, 11(11). https://doi.org/10.1530/ec-22-0378
, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J, & Wass JAH. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Working Group for Renaming Diabetes Insipidus, Arima H, Cheetham T, Endocrine Connections, 11(11). https://doi.org/10.1530/ec-22-0378
, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J, & Wass JAH. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Working Group for Renaming Diabetes Insipidus, Arima H, Cheetham T, European Journal of Endocrinology, 187(5), P1–P3. https://doi.org/10.1530/eje-22-0751
, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J, & Wass JAH. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Working Group for Renaming Diabetes Insipidus, Arima H, Cheetham T, European Journal of Endocrinology, 187(5), P1–P3. https://doi.org/10.1530/eje-22-0751
, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J, & Wass JAH. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Sailer CO, Kuehne JM, da Conceição I, Refardt J, Clinical Endocrinology. https://doi.org/10.1111/cen.14835
, & Winzeler B. (2022). Hypothalamic-pituitary-adrenal axis activity in patients with primary polydipsia compared to healthy controls.
Sailer CO, Kuehne JM, da Conceição I, Refardt J, Clinical Endocrinology. https://doi.org/10.1111/cen.14835
, & Winzeler B. (2022). Hypothalamic-pituitary-adrenal axis activity in patients with primary polydipsia compared to healthy controls.
Atila C, Loughrey PB, Garrahy A, Winzeler B, Refardt J, Gildroy P, Hamza M., Pal A, Verbalis JG, Thompson CJ, Hemkens L.G., Hunter SJ, Sherlock M, Levy MJ, Karavitaki N., Newell-Price J, Wass JAH, & The Lancet Diabetes and Endocrinology, 10(10), 700–709. https://doi.org/10.1016/s2213-8587(22)00219-4
. (2022). Central diabetes insipidus from a patient’s perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey.
Atila C, Loughrey PB, Garrahy A, Winzeler B, Refardt J, Gildroy P, Hamza M., Pal A, Verbalis JG, Thompson CJ, Hemkens L.G., Hunter SJ, Sherlock M, Levy MJ, Karavitaki N., Newell-Price J, Wass JAH, & The Lancet Diabetes and Endocrinology, 10(10), 700–709. https://doi.org/10.1016/s2213-8587(22)00219-4
. (2022). Central diabetes insipidus from a patient’s perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey.
Atila C, Monnerat S, Bingisser R, Siegemund M, Lampart M, Rueegg M, Zellweger N, Osswald S, Rentsch K, Endocrine Connections, 11(10). https://doi.org/10.1530/ec-22-0171
, & Twerenbold R. (2022). Inverse relationship between IL-6 and sodium levels in patients with COVID-19 and other respiratory tract infections: data from the COVIVA study.
Atila C, Monnerat S, Bingisser R, Siegemund M, Lampart M, Rueegg M, Zellweger N, Osswald S, Rentsch K, Endocrine Connections, 11(10). https://doi.org/10.1530/ec-22-0171
, & Twerenbold R. (2022). Inverse relationship between IL-6 and sodium levels in patients with COVID-19 and other respiratory tract infections: data from the COVIVA study.
Arima H, Cheetham T, Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus. https://doi.org/10.1111/cen.14819
, Cooper D, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG, & Wass J. (2022, August 28).
Arima H, Cheetham T, Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus. https://doi.org/10.1111/cen.14819
, Cooper D, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG, & Wass J. (2022, August 28).
Atila C, Monnerat S, Urwyler SA, Refardt J, Winzeler B, & Pituitary, 25(4), 636–644. https://doi.org/10.1007/s11102-022-01240-0
. (2022). The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults : Data from: Glucacop, Macicop, and CARGO study.
Atila C, Monnerat S, Urwyler SA, Refardt J, Winzeler B, & Pituitary, 25(4), 636–644. https://doi.org/10.1007/s11102-022-01240-0
. (2022). The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults : Data from: Glucacop, Macicop, and CARGO study.
Bicvic A, Scherrer N, Schweizer J, Fluri F, European Stroke Journal, 7(2), 158–165. https://doi.org/10.1177/23969873221090798
, De Marchis GM, Luft AR, & Katan M. (2022). A novel biomarker panel index improves risk stratification after ischemic stroke.
Bicvic A, Scherrer N, Schweizer J, Fluri F, European Stroke Journal, 7(2), 158–165. https://doi.org/10.1177/23969873221090798
, De Marchis GM, Luft AR, & Katan M. (2022). A novel biomarker panel index improves risk stratification after ischemic stroke.
The Journal of Clinical Endocrinology and Metabolism, 107(6), 1727–1738. https://doi.org/10.1210/clinem/dgac070
, Refardt J, & Winzeler B. (2022). Approach to the Patient: “Utility of the Copeptin Assay”.
The Journal of Clinical Endocrinology and Metabolism, 107(6), 1727–1738. https://doi.org/10.1210/clinem/dgac070
, Refardt J, & Winzeler B. (2022). Approach to the Patient: “Utility of the Copeptin Assay”.
Vukajlovic T, Sailer CO, Asmar A, Jensen BL, Vogt DR, The Journal of Clinical Endocrinology and Metabolism, 107(6), e2581–e2589. https://doi.org/10.1210/clinem/dgac063
, & Winzeler B. (2022). Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
Vukajlovic T, Sailer CO, Asmar A, Jensen BL, Vogt DR, The Journal of Clinical Endocrinology and Metabolism, 107(6), e2581–e2589. https://doi.org/10.1210/clinem/dgac063
, & Winzeler B. (2022). Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
Atila C, Gaisl O, Vogt DR, Werlen L, Szinnai G, & European Journal of Endocrinology, 187(1), 65–74. https://doi.org/10.1530/eje-22-0033
. (2022). Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study.
Atila C, Gaisl O, Vogt DR, Werlen L, Szinnai G, & European Journal of Endocrinology, 187(1), 65–74. https://doi.org/10.1530/eje-22-0033
. (2022). Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study.
Atila, C., Monnerat, S., Urwyler, S. A., Refardt, J., Winzeler, B., & Christ-Crain, M. (2022, May 12). The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults [Posted-content]. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-1636018/v1
Atila, C., Monnerat, S., Urwyler, S. A., Refardt, J., Winzeler, B., & Christ-Crain, M. (2022, May 12). The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults [Posted-content]. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-1636018/v1
Borisov AN, Blum CA, Nutrition & Diabetes, 12(1), 12. https://doi.org/10.1038/s41387-022-00190-7
, & Ebrahimi F. (2022). No obesity paradox in patients with community-acquired pneumonia - secondary analysis of a randomized controlled trial.
Borisov AN, Blum CA, Nutrition & Diabetes, 12(1), 12. https://doi.org/10.1038/s41387-022-00190-7
, & Ebrahimi F. (2022). No obesity paradox in patients with community-acquired pneumonia - secondary analysis of a randomized controlled trial.
Sailer, C. O., Kühne, J. M., Conceição, I. d., Refardt, J., Christ-Crain, M., & Winzeler, B. (2022, March 3). Hypothalamic-pituitary-adrenal axis activity in patients with primary polydipsia compared to healthy volunteers [Posted-content]. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-1370576/v1
Sailer, C. O., Kühne, J. M., Conceição, I. d., Refardt, J., Christ-Crain, M., & Winzeler, B. (2022, March 3). Hypothalamic-pituitary-adrenal axis activity in patients with primary polydipsia compared to healthy volunteers [Posted-content]. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-1370576/v1
Tritos NA, Fazeli PK, McCormack A, Mallea-Gil SM, Pineyro MM, Pituitary, 25(1), 64–73. https://doi.org/10.1007/s11102-021-01170-3
, Frara S, Labadzhyan A, Ioachimescu AG, Shimon I, Takahashi Y, Gurnell M, Fleseriu M, & “Pituitary Society Delphi Collaborative Group”. (2022). Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas.
Tritos NA, Fazeli PK, McCormack A, Mallea-Gil SM, Pineyro MM, Pituitary, 25(1), 64–73. https://doi.org/10.1007/s11102-021-01170-3
, Frara S, Labadzhyan A, Ioachimescu AG, Shimon I, Takahashi Y, Gurnell M, Fleseriu M, & “Pituitary Society Delphi Collaborative Group”. (2022). Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas.
Potasso L, Refardt J, De Marchis GM, Wiencierz A, Wright PR, Wagner B, Dittrich T, Polymeris AA, Gensicke H, Bonati LH, & The Journal of Clinical Endocrinology and Metabolism, 107(2), e672–e680. https://doi.org/10.1210/clinem/dgab650
. (2022). Impact of Sodium Levels on Functional Outcomes in Patients With Stroke - A Swiss Stroke Registry Analysis.
Potasso L, Refardt J, De Marchis GM, Wiencierz A, Wright PR, Wagner B, Dittrich T, Polymeris AA, Gensicke H, Bonati LH, & The Journal of Clinical Endocrinology and Metabolism, 107(2), e672–e680. https://doi.org/10.1210/clinem/dgab650
. (2022). Impact of Sodium Levels on Functional Outcomes in Patients With Stroke - A Swiss Stroke Registry Analysis.
Liberale, Luca, Ministrini, Stefano, Arnold, Markus, Puspitasari, Yustina M., Pokorny, Thomas, Beer, Georgia, Scherrer, Natalie, Schweizer, Juliane, Scientific Reports, 12. https://doi.org/10.1038/s41598-022-23211-y
, Montecucco, Fabrizio, Camici, Giovanni G., & Katan Kahles, Mira. (2022). Serum circulating sirtuin 6 as a novel predictor of mortality after acute ischemic stroke.
Liberale, Luca, Ministrini, Stefano, Arnold, Markus, Puspitasari, Yustina M., Pokorny, Thomas, Beer, Georgia, Scherrer, Natalie, Schweizer, Juliane, Scientific Reports, 12. https://doi.org/10.1038/s41598-022-23211-y
, Montecucco, Fabrizio, Camici, Giovanni G., & Katan Kahles, Mira. (2022). Serum circulating sirtuin 6 as a novel predictor of mortality after acute ischemic stroke.
Potasso L, Potasso L, Refardt J., Meier C, & European Journal of Endocrinology, 186(1), 1–8. https://doi.org/10.1530/eje-21-0604
(2022). Effect of hyponatremia normalization on osteoblast function in patients with SIAD.
Potasso L, Potasso L, Refardt J., Meier C, & European Journal of Endocrinology, 186(1), 1–8. https://doi.org/10.1530/eje-21-0604
(2022). Effect of hyponatremia normalization on osteoblast function in patients with SIAD.
Wittermans E, van der Zee PA, Qi H., van de Garde EMW, Blum CA, ERJ Open Research, 8(1). https://doi.org/10.1183/23120541.00489-2021
, Gommers D, Grutters JC, Voorn GP, Bos WJW, & Endeman H. (2022). Community-acquired pneumonia subgroups and differential response to corticosteroids: a secondary analysis of controlled studies.
Wittermans E, van der Zee PA, Qi H., van de Garde EMW, Blum CA, ERJ Open Research, 8(1). https://doi.org/10.1183/23120541.00489-2021
, Gommers D, Grutters JC, Voorn GP, Bos WJW, & Endeman H. (2022). Community-acquired pneumonia subgroups and differential response to corticosteroids: a secondary analysis of controlled studies.
Berkmann S, Roethlisberger M, Mueller B, Pituitary, 24(6), 878–886. https://doi.org/10.1007/s11102-021-01160-5
, Mariani L., Nitzsche E, & Juengling F. (2021). Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI.
Berkmann S, Roethlisberger M, Mueller B, Pituitary, 24(6), 878–886. https://doi.org/10.1007/s11102-021-01160-5
, Mariani L., Nitzsche E, & Juengling F. (2021). Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI.
Presse Medicale (Paris, France : 1983), 50(4), 104093. https://doi.org/10.1016/j.lpm.2021.104093
, & Gaisl O. (2021). Diabetes insipidus.
Presse Medicale (Paris, France : 1983), 50(4), 104093. https://doi.org/10.1016/j.lpm.2021.104093
, & Gaisl O. (2021). Diabetes insipidus.
Sailer C.O., Refardt J, Blum CA, Schnyder I, Molina-Tijeras J.A., Fenske W., Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-89505-9
, & (2021). Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome.
Sailer C.O., Refardt J, Blum CA, Schnyder I, Molina-Tijeras J.A., Fenske W., Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-89505-9
, & (2021). Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome.
Nobbenhuis R, Nobbenhuis R, Refardt J, Vogt D, Sailer CO, Winzeler B, & Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 26(7), 647–655. https://doi.org/10.1080/1354750x.2021.1970808
. (2021). Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers?
Nobbenhuis R, Nobbenhuis R, Refardt J, Vogt D, Sailer CO, Winzeler B, & Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 26(7), 647–655. https://doi.org/10.1080/1354750x.2021.1970808
. (2021). Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers?
Raess N., Schuetz P., Cesana-Nigro N., Winzeler B, Urwyler SA, Schaedelin S., Rodondi N, Blum M.R., Briel M., Mueller B, Journal of Clinical Pharmacology, 61(11), 1406–1414. https://doi.org/10.1002/jcph.1914
, & Blum CA. (2021). Influence of Prednisone on Inflammatory Biomarkers in Community-Acquired Pneumonia: Secondary Analysis of a Randomized Trial.
Raess N., Schuetz P., Cesana-Nigro N., Winzeler B, Urwyler SA, Schaedelin S., Rodondi N, Blum M.R., Briel M., Mueller B, Journal of Clinical Pharmacology, 61(11), 1406–1414. https://doi.org/10.1002/jcph.1914
, & Blum CA. (2021). Influence of Prednisone on Inflammatory Biomarkers in Community-Acquired Pneumonia: Secondary Analysis of a Randomized Trial.
Heilmann E., Gregoriano C., Annane D., Reinhart K., Bouadma L., Wolff M., Chastre J., Luyt C.-E., Tubach F., Branche A.R., Briel M., Age and Ageing, 50(5), 1546–1556. https://doi.org/10.1093/ageing/afab078
, Welte T., Corti C., De Jong E., Nijsten M., De Lange D.W., Van Oers J.A.H., Beishuizen A., et al. (2021). Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: A patient-level meta-analysis from randomized controlled trials.
Heilmann E., Gregoriano C., Annane D., Reinhart K., Bouadma L., Wolff M., Chastre J., Luyt C.-E., Tubach F., Branche A.R., Briel M., Age and Ageing, 50(5), 1546–1556. https://doi.org/10.1093/ageing/afab078
, Welte T., Corti C., De Jong E., Nijsten M., De Lange D.W., Van Oers J.A.H., Beishuizen A., et al. (2021). Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: A patient-level meta-analysis from randomized controlled trials.
ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: The management of diabetes insipidus and hyponatraemia. (Patent No. 4). 185(4), Article 4. https://doi.org/10.1530/eje-21-0596
, Hoorn EJ, Sherlock M, Thompson CJ, & Wass J. (2021).
ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: The management of diabetes insipidus and hyponatraemia. (Patent No. 4). 185(4), Article 4. https://doi.org/10.1530/eje-21-0596
, Hoorn EJ, Sherlock M, Thompson CJ, & Wass J. (2021).
Sailer C.O., Winzeler B, Urwyler SA, Schnyder I., Refardt J, Eckert A., Varghese N., Fassnacht M., Chifu I., Lawson E.A., Verbalis J.G., Fenske W., & European Journal of Endocrinology, 185(3), 355–364. https://doi.org/10.1530/eje-21-0346
. (2021). Oxytocin levels in response to pituitary provocation tests in healthy volunteers.
Sailer C.O., Winzeler B, Urwyler SA, Schnyder I., Refardt J, Eckert A., Varghese N., Fassnacht M., Chifu I., Lawson E.A., Verbalis J.G., Fenske W., & European Journal of Endocrinology, 185(3), 355–364. https://doi.org/10.1530/eje-21-0346
. (2021). Oxytocin levels in response to pituitary provocation tests in healthy volunteers.
Urwyler SA, Lustenberger S, Drummond JR, Soares BS, Vogt DR, Ammer N, Yuen KCJ, Ribeiro-Oliveira A, & Pituitary, 24(4), 555–563. https://doi.org/10.1007/s11102-021-01132-9
. (2021). Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers.
Urwyler SA, Lustenberger S, Drummond JR, Soares BS, Vogt DR, Ammer N, Yuen KCJ, Ribeiro-Oliveira A, & Pituitary, 24(4), 555–563. https://doi.org/10.1007/s11102-021-01132-9
. (2021). Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers.
Journal of Internal Medicine, 290(1), 73–87. https://doi.org/10.1111/joim.13261
, Winzeler B, & Refardt J. (2021). Diagnosis and management of diabetes insipidus for the internist: an update.
Journal of Internal Medicine, 290(1), 73–87. https://doi.org/10.1111/joim.13261
, Winzeler B, & Refardt J. (2021). Diagnosis and management of diabetes insipidus for the internist: an update.
Tsagkas C, Schäfer S, Baumgartner A, Müller J, Sinnecker T, Mehling M, van der Stouwe JG, Felder S, Panagiotou A, Potlukova E, Winzeler B, Scholz MC, Timper K, Blackham K, Nickel CH, Lancet (London, England), 397(10290), 2194. https://doi.org/10.1016/s0140-6736(21)00986-7
, Bingisser R, Lyrer P, Kappos L, & Yaldizli Ö. (2021). Syndrome of inappropriate antidiuretic hormone secretion and hypothalamic hypocortisolism in neuromyelitis optica.
Tsagkas C, Schäfer S, Baumgartner A, Müller J, Sinnecker T, Mehling M, van der Stouwe JG, Felder S, Panagiotou A, Potlukova E, Winzeler B, Scholz MC, Timper K, Blackham K, Nickel CH, Lancet (London, England), 397(10290), 2194. https://doi.org/10.1016/s0140-6736(21)00986-7
, Bingisser R, Lyrer P, Kappos L, & Yaldizli Ö. (2021). Syndrome of inappropriate antidiuretic hormone secretion and hypothalamic hypocortisolism in neuromyelitis optica.
Fischli S, Von Wyl V., Wuillemin W., Von Kanel R., Schütz P, Journal of the Endocrine Society, 5(5). https://doi.org/10.1210/jendso/bvab047
, Studer F., Brander L., Schupfer G., Metzger J, & Henzen C. (2021). Impact of adrenal function on Hemostasis/Endothelial function in patients undergoing surgery.
Fischli S, Von Wyl V., Wuillemin W., Von Kanel R., Schütz P, Journal of the Endocrine Society, 5(5). https://doi.org/10.1210/jendso/bvab047
, Studer F., Brander L., Schupfer G., Metzger J, & Henzen C. (2021). Impact of adrenal function on Hemostasis/Endothelial function in patients undergoing surgery.
Atila C., Sailer C.O., Bassetti S., Tschudin-Sutter S, Bingisser R., Siegemund M, Osswald S, Rentsch K, Rueegg M., Schaerli S., Kuster GM, Twerenbold R, & European Journal of Endocrinology, 184(3), 409–418. https://doi.org/10.1530/eje-20-1374
. (2021). Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls.
Atila C., Sailer C.O., Bassetti S., Tschudin-Sutter S, Bingisser R., Siegemund M, Osswald S, Rentsch K, Rueegg M., Schaerli S., Kuster GM, Twerenbold R, & European Journal of Endocrinology, 184(3), 409–418. https://doi.org/10.1530/eje-20-1374
. (2021). Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls.
Stormann S., Schopohl J., Bullmann C., Terkamp C., Experimental and Clinical Endocrinology and Diabetes, 129(3), 224–233. https://doi.org/10.1055/a-1247-4713
, Finke R., Flitsch J., Kreitschmann-Andermahr I., Luger A., Stalla G., Houchard A., Helbig D., & Petersenn S. (2021). Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and Switzerland.
Stormann S., Schopohl J., Bullmann C., Terkamp C., Experimental and Clinical Endocrinology and Diabetes, 129(3), 224–233. https://doi.org/10.1055/a-1247-4713
, Finke R., Flitsch J., Kreitschmann-Andermahr I., Luger A., Stalla G., Houchard A., Helbig D., & Petersenn S. (2021). Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and Switzerland.
Heilmann E, Gregoriano C, Wirz Y, Luyt CE, Wolff M, Chastre J, Tubach F, Clinical Chemistry and Laboratory Medicine, 59(2), 441–453. https://doi.org/10.1515/cclm-2020-0931
, Bouadma L, Annane D, Damas P, Kristoffersen KB, Oliveira CF, Stolz D, Tamm M., de Jong E, Reinhart K, Shehabi Y, Verduri A, et al. (2021). Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: A patient-level meta-analysis from randomized controlled trials.
Heilmann E, Gregoriano C, Wirz Y, Luyt CE, Wolff M, Chastre J, Tubach F, Clinical Chemistry and Laboratory Medicine, 59(2), 441–453. https://doi.org/10.1515/cclm-2020-0931
, Bouadma L, Annane D, Damas P, Kristoffersen KB, Oliveira CF, Stolz D, Tamm M., de Jong E, Reinhart K, Shehabi Y, Verduri A, et al. (2021). Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: A patient-level meta-analysis from randomized controlled trials.
Westphal L.P., Schweizer J., Fluri F., De Marchis GM, Frontiers in Neurology, 11. https://doi.org/10.3389/fneur.2020.629151
, Luft A.R., & Katan M. (2021). C-Terminal-Pro-Endothelin-1 Adds Incremental Prognostic Value for Risk Stratification After Ischemic Stroke.
Westphal L.P., Schweizer J., Fluri F., De Marchis GM, Frontiers in Neurology, 11. https://doi.org/10.3389/fneur.2020.629151
, Luft A.R., & Katan M. (2021). C-Terminal-Pro-Endothelin-1 Adds Incremental Prognostic Value for Risk Stratification After Ischemic Stroke.
Endocrinological diagnosis and replacement therapy for diabetes insipidus (pp. 147–156). Elsevier. https://doi.org/10.1016/b978-0-12-819949-7.00021-4
(2021).
Endocrinological diagnosis and replacement therapy for diabetes insipidus (pp. 147–156). Elsevier. https://doi.org/10.1016/b978-0-12-819949-7.00021-4
(2021).
Ebrahimi, Fahim, Urwyler, Sandrine Andrea, Betz, Matthias Johannes, Christ, Emanuel Remigius, Schuetz, Philipp, Müller, Beat, Donath, Marc Yves, & Scientific Reports, 11(1), 7911. https://doi.org/10.1038/s41598-021-87207-w
. (2021). Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome.
Ebrahimi, Fahim, Urwyler, Sandrine Andrea, Betz, Matthias Johannes, Christ, Emanuel Remigius, Schuetz, Philipp, Müller, Beat, Donath, Marc Yves, & Scientific Reports, 11(1), 7911. https://doi.org/10.1038/s41598-021-87207-w
. (2021). Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome.
Ebrahimi F., Urwyler S.A., Betz M.J., Christ E.R., Schuetz P., Mueller B., Donath M.Y., & Scientific Reports, 11. https://doi.org/10.1038/s41598-021-87207-w
(2021). Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome.
Ebrahimi F., Urwyler S.A., Betz M.J., Christ E.R., Schuetz P., Mueller B., Donath M.Y., & Scientific Reports, 11. https://doi.org/10.1038/s41598-021-87207-w
(2021). Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome.
Potasso, Laura, Refardt, Julie, De Marchis, Gian Marco, Wiencierz, Andrea, Wright, Patrick R, Wagner, Benjamin, Dittrich, Tolga, Polymeris, Alexandros A, Gensicke, Henrik, Bonati, Leo H, & The Journal of Clinical Endocrinology and Metabolism, dgab650. https://doi.org/10.1210/clinem/dgab650
. (2021). Impact of Sodium Levels on Functional Outcomes in Patients with Stroke - A Swiss Stroke Registry Analysis.
Potasso, Laura, Refardt, Julie, De Marchis, Gian Marco, Wiencierz, Andrea, Wright, Patrick R, Wagner, Benjamin, Dittrich, Tolga, Polymeris, Alexandros A, Gensicke, Henrik, Bonati, Leo H, & The Journal of Clinical Endocrinology and Metabolism, dgab650. https://doi.org/10.1210/clinem/dgab650
. (2021). Impact of Sodium Levels on Functional Outcomes in Patients with Stroke - A Swiss Stroke Registry Analysis.
Potasso L, Potasso L, Refardt J., Chifu I., Fassnacht M, Fenske W.K., & Endocrine Connections, 10(4), 401–409. https://doi.org/10.1530/ec-20-0531
(2021). Incidence of hyperkalemia during hypertonic saline test for the diagnosis of diabetes insipidus.
Potasso L, Potasso L, Refardt J., Chifu I., Fassnacht M, Fenske W.K., & Endocrine Connections, 10(4), 401–409. https://doi.org/10.1530/ec-20-0531
(2021). Incidence of hyperkalemia during hypertonic saline test for the diagnosis of diabetes insipidus.
Refardt J, Pelouto A, Potasso L, Hoorn EJ, & Frontiers in Medicine, 8, 729545. https://doi.org/10.3389/fmed.2021.729545
. (2021). Hyponatremia Intervention Trial (HIT): Study Protocol of a Randomized, Controlled, Parallel-Group Trial With Blinded Outcome Assessment.
Refardt J, Pelouto A, Potasso L, Hoorn EJ, & Frontiers in Medicine, 8, 729545. https://doi.org/10.3389/fmed.2021.729545
. (2021). Hyponatremia Intervention Trial (HIT): Study Protocol of a Randomized, Controlled, Parallel-Group Trial With Blinded Outcome Assessment.
Winzeler, Bettina, Sailer, Clara O, Coynel, David, Zanchi, Davide, Vogt, Deborah R, Urwyler, Sandrine A, Refardt, Julie, & The Journal of Clinical Investigation, 131(20), e151800. https://doi.org/10.1172/jci151800
. (2021). A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia.
Winzeler, Bettina, Sailer, Clara O, Coynel, David, Zanchi, Davide, Vogt, Deborah R, Urwyler, Sandrine A, Refardt, Julie, & The Journal of Clinical Investigation, 131(20), e151800. https://doi.org/10.1172/jci151800
. (2021). A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia.
Winzeler B, Sailer C.O., Coynel D., Zanchi D., Vogt DR, Urwyler SA, Refardt J, & Journal of Clinical Investigation, 131(20). https://doi.org/10.1172/jci151800
(2021). A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia.
Winzeler B, Sailer C.O., Coynel D., Zanchi D., Vogt DR, Urwyler SA, Refardt J, & Journal of Clinical Investigation, 131(20). https://doi.org/10.1172/jci151800
(2021). A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia.
Drummond JB, Soares BS, Pedrosa W, Vieira ELM, Teixeira AL, Pituitary, 23(6), 681–690. https://doi.org/10.1007/s11102-020-01076-6
, & Ribeiro-Oliveira A Jr. (2020). Copeptin response to hypoglycemic stress is linked to prolactin activation in children.
Drummond JB, Soares BS, Pedrosa W, Vieira ELM, Teixeira AL, Pituitary, 23(6), 681–690. https://doi.org/10.1007/s11102-020-01076-6
, & Ribeiro-Oliveira A Jr. (2020). Copeptin response to hypoglycemic stress is linked to prolactin activation in children.
Austrian Journal of Clinical Endocrinology and Metabolism, 13(4), 142–150. https://doi.org/10.1007/s41969-020-00106-9
(2020). Copeptin—its value for the diagnosis of polyuria-polydipsia syndrome Copeptin – Stellenwert in der Diagnostik des Polyurie-Polydipsie-Syndroms.
Austrian Journal of Clinical Endocrinology and Metabolism, 13(4), 142–150. https://doi.org/10.1007/s41969-020-00106-9
(2020). Copeptin—its value for the diagnosis of polyuria-polydipsia syndrome Copeptin – Stellenwert in der Diagnostik des Polyurie-Polydipsie-Syndroms.
Ebrahimi F, Kutz A, Wagner U, Illigens B, Siepmann T, Schuetz P, The Journal of Clinical Endocrinology and Metabolism, 105(11). https://doi.org/10.1210/clinem/dgaa517
, Mueller B, Mueller B, & Christ ER. (2020). Excess Mortality Among Hospitalized Patients With Hypopituitarism-A Population-Based, Matched-Cohort Study.
Ebrahimi F, Kutz A, Wagner U, Illigens B, Siepmann T, Schuetz P, The Journal of Clinical Endocrinology and Metabolism, 105(11). https://doi.org/10.1210/clinem/dgaa517
, Mueller B, Mueller B, & Christ ER. (2020). Excess Mortality Among Hospitalized Patients With Hypopituitarism-A Population-Based, Matched-Cohort Study.
Kutz A, Ebrahimi F, Aghlmandi S, Wagner U, Bromley M, Illigens B, Siepmann T, Schuetz P, The Journal of Clinical Endocrinology and Metabolism, 105(11), 3428–3436. https://doi.org/10.1210/clinem/dgaa547
, , & Christ-Crain M. (2020). Risk of Adverse Clinical Outcomes in Hyponatremic Adult Patients Hospitalized for Acute Medical Conditions: A Population-Based Cohort Study.
Kutz A, Ebrahimi F, Aghlmandi S, Wagner U, Bromley M, Illigens B, Siepmann T, Schuetz P, The Journal of Clinical Endocrinology and Metabolism, 105(11), 3428–3436. https://doi.org/10.1210/clinem/dgaa547
, , & Christ-Crain M. (2020). Risk of Adverse Clinical Outcomes in Hyponatremic Adult Patients Hospitalized for Acute Medical Conditions: A Population-Based Cohort Study.
Winzeler B, da Conceição I, Refardt J, Sailer CO, Dutilh G, & Endocrine, 70(2), 292–298. https://doi.org/10.1007/s12020-020-02394-2
. (2020). Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteers.
Winzeler B, da Conceição I, Refardt J, Sailer CO, Dutilh G, & Endocrine, 70(2), 292–298. https://doi.org/10.1007/s12020-020-02394-2
. (2020). Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteers.
Winzeler B, Morin B, Refardt J, Imber C, Fenske W, Sailer CO, Holbro A, & Clinical Endocrinology, 93(4), 456–465. https://doi.org/10.1111/cen.14265
. (2020). Low arginine vasopressin levels in patients with diabetes insipidus are not associated with anaemia.
Winzeler B, Morin B, Refardt J, Imber C, Fenske W, Sailer CO, Holbro A, & Clinical Endocrinology, 93(4), 456–465. https://doi.org/10.1111/cen.14265
. (2020). Low arginine vasopressin levels in patients with diabetes insipidus are not associated with anaemia.
Diabetes insipidus - An update in diagnosis and management. (Patent No. 5). 34(5), Article 5. https://doi.org/10.1016/j.beem.2020.101470
. (2020).
Diabetes insipidus - An update in diagnosis and management. (Patent No. 5). 34(5), Article 5. https://doi.org/10.1016/j.beem.2020.101470
. (2020).
Refardt J, Winzeler B, & Endocrinology and Metabolism Clinics of North America, 49(3), 517–531. https://doi.org/10.1016/j.ecl.2020.05.012
. (2020). Diabetes Insipidus: An Update.
Refardt J, Winzeler B, & Endocrinology and Metabolism Clinics of North America, 49(3), 517–531. https://doi.org/10.1016/j.ecl.2020.05.012
. (2020). Diabetes Insipidus: An Update.
Potasso L, Potasso L, Sailer CO, Blum CA, & Hyponatremia at discharge: A solid risk or accidental findings in community acquired pneumonia - Authors’ reply. 78, 137–138. https://doi.org/10.1016/j.ejim.2020.07.004
. (2020).
Potasso L, Potasso L, Sailer CO, Blum CA, & Hyponatremia at discharge: A solid risk or accidental findings in community acquired pneumonia - Authors’ reply. 78, 137–138. https://doi.org/10.1016/j.ejim.2020.07.004
. (2020).
Bologna K, Cesana-Nigro N, Refardt J, Imber C, Vogt DR, The Journal of Clinical Endocrinology and Metabolism, 105(7). https://doi.org/10.1210/clinem/dgaa157
, & Winzeler B. (2020). Effect of Arginine on the Hypothalamic-Pituitary-Adrenal Axis in Individuals With and Without Vasopressin Deficiency.
Bologna K, Cesana-Nigro N, Refardt J, Imber C, Vogt DR, The Journal of Clinical Endocrinology and Metabolism, 105(7). https://doi.org/10.1210/clinem/dgaa157
, & Winzeler B. (2020). Effect of Arginine on the Hypothalamic-Pituitary-Adrenal Axis in Individuals With and Without Vasopressin Deficiency.
European Journal of Endocrinology, 183(1), G9–G15. https://doi.org/10.1530/eje-20-0338
, Hoorn EJ, Sherlock M, Thompson CJ, & Wass JAH. (2020). ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia.
European Journal of Endocrinology, 183(1), G9–G15. https://doi.org/10.1530/eje-20-0338
, Hoorn EJ, Sherlock M, Thompson CJ, & Wass JAH. (2020). ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia.
Popovic M, Ebrahimi F, Urwyler SA, Donath MY, & Endocrine Connections, 9(7), 715–723. https://doi.org/10.1530/ec-20-0197
. (2020). The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome.
Popovic M, Ebrahimi F, Urwyler SA, Donath MY, & Endocrine Connections, 9(7), 715–723. https://doi.org/10.1530/ec-20-0197
. (2020). The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome.
Arnold M., Nakas C, Stroke, 51(6), 1873–1875. https://doi.org/10.1161/strokeaha.120.029333
, Christ-Crain M, Leichtle A, & Katan M. (2020). Independent Prognostic Value of MRproANP (Midregional Proatrial Natriuretic Peptide) Levels in Patients With Stroke Is Unaltered Over Time.
Arnold M., Nakas C, Stroke, 51(6), 1873–1875. https://doi.org/10.1161/strokeaha.120.029333
, Christ-Crain M, Leichtle A, & Katan M. (2020). Independent Prognostic Value of MRproANP (Midregional Proatrial Natriuretic Peptide) Levels in Patients With Stroke Is Unaltered Over Time.